|
⚲
|
| Keyboard |
| Insignis Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001981826 |
| Sale | 2026-06-11 (8.5 M Offered, 6.0 M Sold) |
| Fund | |
| Phone | 2035708879 |
| Address | 410 Sackett Point Road North Haven, CT 06473 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-08-05 (D) |
| Exemption | 506(b) |
| Minimum | $1 |
| Remaining | $2,500,286 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Mingbao Zhang | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Marketfield Asset Management LLC
✚
|
CT | |
|
Discovery Capital Management LLC / CT
✚
|
CT | |
|
Lascaux Resource Capital LLC
✚
|
CT | |
|
Fieldpoint Private Securities LLC
✚
|
CT | |
|
Rubric Capital Management LLC
✚
|
CT | |
|
Prospector Partners LLC
✚
|
CT | |
|
Ocean Park Investments LP
✚
|
CT | |
|
AQR Capital Management Holdings LLC
✚
|
CT | |
|
Gamco Investors Inc ET AL
✚
|
CT | |
|
NGN Capital LLC
✚
|
CT |